88 related articles for article (PubMed ID: 6322984)
1. Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices.
Freake HC; Abeyasekera G; Iwasaki J; Marcocci C; MacIntyre I; McClelland RA; Skilton RA; Easton DF; Coombes RC
Cancer Res; 1984 Apr; 44(4):1677-81. PubMed ID: 6322984
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites.
Frampton RJ; Omond SA; Eisman JA
Cancer Res; 1983 Sep; 43(9):4443-7. PubMed ID: 6307514
[TBL] [Abstract][Full Text] [Related]
3. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
4. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
5. Systematic search for 1 alpha,25-dihydroxy-vitamin D3 receptors in human breast carcinomas.
Ulmann A; Brami M; Corcos D; Bader C; Delarue JC; Contesso G
Biomed Pharmacother; 1984; 38(4):204-8. PubMed ID: 6093907
[TBL] [Abstract][Full Text] [Related]
6. Specific uptake of 1,25-dihydroxycholecalciferol by human chronic myeloid leukemia cells.
Freake HC; Iwasaki J; McCarthy DM
Cancer Res; 1984 Aug; 44(8):3627-31. PubMed ID: 6331655
[TBL] [Abstract][Full Text] [Related]
7. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
Frampton RJ; Suva LJ; Eisman JA; Findlay DM; Moore GE; Moseley JM; Martin TJ
Cancer Res; 1982 Mar; 42(3):1116-9. PubMed ID: 6277475
[TBL] [Abstract][Full Text] [Related]
8. 1,25-dihydroxyvitamin D3 and breast cancer.
Eisman JA; Suva LJ; Frampton RJ
Aust N Z J Surg; 1984 Feb; 54(1):17-20. PubMed ID: 6326729
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 receptor measurement in primary renal cell carcinomas and autologous normal kidney tissue.
Trydal T; Bakke A; Aksnes L; Aarskog D
Cancer Res; 1988 May; 48(9):2458-61. PubMed ID: 2833346
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer.
Berger U; Wilson P; McClelland RA; Colston K; Haussler MR; Pike JW; Coombes RC
Cancer Res; 1987 Dec; 47(24 Pt 1):6793-9. PubMed ID: 2824042
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
[TBL] [Abstract][Full Text] [Related]
14. Frequency of 1,25-dihydroxyvitamin D3 receptor in human breast cancer.
Eisman JA; Suva LJ; Sher E; Pearce PJ; Funder JW; Martin TJ
Cancer Res; 1981 Dec; 41(12 Pt 1):5121-4. PubMed ID: 6272989
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 binding in estrogen-responsive rat breast tumor.
Colston K; Wilkinson JR; Coombes RC
Endocrinology; 1986 Jul; 119(1):397-403. PubMed ID: 3013595
[TBL] [Abstract][Full Text] [Related]
16. Significance of 1,25-dihydroxyvitamin D3 receptor in primary breast cancers.
Eisman JA; Suva LJ; Martin TJ
Cancer Res; 1986 Oct; 46(10):5406-8. PubMed ID: 3019526
[TBL] [Abstract][Full Text] [Related]
17. Presence of 1,25-dihydroxy vitamin D receptor in normal and abnormal breast tissue.
Eisman JA; Martin TJ; MacIntyre I
Prog Biochem Pharmacol; 1980; 17():143-50. PubMed ID: 6259652
[TBL] [Abstract][Full Text] [Related]
18. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
19. Specific cytosol binding proteins for 25(OH)D3 and 1.25(OH)2D3 in human breast cancers.
Nakata M; Tsuboi S; Takenaka M; Konishi Y; Kawashima R; Tomita M; Nakagawa T; Iwamura N; Fujita T
Endocrinol Jpn; 1981 Dec; 28(6):741-6. PubMed ID: 6286292
[TBL] [Abstract][Full Text] [Related]
20. Temperature-dependent alteration of 1,25-dihydroxy-vitamin D3 receptor macromolecules in MC3T3-E1 cells: affinity of hexafluoro analog of 1,25-dihydroxyvitamin D3, ST-630, for these forms.
Tanaka M; Muramatsu M; Higuchi S; Otomo S
Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):3-13. PubMed ID: 7953192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]